BCAT2 and bladder transitional cell carcinoma: In our study, through comprehensive analysis of TME‐related indicators in Xiangya BLCA cohort and multiple public BLCA cohorts, we screened that BCAT2 probably shapes an immunosuppressive TME in BLCA.